Evidence map›Paper›PMID 23254563›Full record

ReviewMetabolic brain disease2013

In vivo studies of brain metabolism in animal models of Hepatic Encephalopathy using ¹H Magnetic Resonance Spectroscopy.

Cristina Cudalbu

Open access · greenAbstract readReview
PubMed Publisher
In one paragraph

Review in Metabolic brain disease, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Hyperammonemia in Inherited Metabolic Diseases.Cellular and molecular neurobiology · 2022
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Ammonia toxicity: from head to toe?Metabolic brain disease · 2017
    Review
  10. Review
  11. Review
  12. Metabolic brain disease · 2016
    Article
  13. Article
  14. Article
  15. Brain Edema in Chronic Hepatic Encephalopathy.Journal of clinical and experimental hepatology
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Cristina CudalbuEcole Polytechnique Fédérale de Lausanne, Laboratory for Functional and Metabolic Imaging, Station 6, CH F1 602 (Bâtiment CH), 1015 Lausanne, Switzerland. cristina.cudalbu@epfl.ch
École Polytechnique Fédérale de Lausanne · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatic encephalopathy (HE) is a common and severe neuropsychiatric complication present in acute and chronic liver disease. The unique advantages of high field (1)H MRS provide a method for assessing pathogenic mechanism, diagnosis and monitoring of HE, as well as for treatment assessment or recovery after liver transplantation, in a reproducible and reliable non-invasive way. The purpose of the present review is to present some new features of in vivo proton Magnetic Resonance Spectroscopy ((1)H MRS) at high magnetic fields combined with some basic requirements for reliable metabolic profiling. Finally, in vivo applications of (1)H MRS in different HE animal models are presented.

Indexed as

AnimalsBrainBrain ChemistryElectromagnetic FieldsEnd Stage Liver DiseaseHepatic EncephalopathyHumansHyperammonemiaLiver Failure, AcuteMagnetic Resonance Spectroscopy

Identifiers

PMID23254563
OpenAlexW1978612253

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.